Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $83.1 million.

  • Autolus Therapeutics' Total Current Liabilities rose 58.31% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year increase of 58.31%. This contributed to the annual value of $60.7 million for FY2024, which is 35.78% up from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Total Current Liabilities is $83.1 million, which was up 21.89% from $68.2 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Total Current Liabilities high stood at $83.1 million for Q3 2025, and its period low was $28.2 million during Q2 2021.
  • In the last 3 years, Autolus Therapeutics' Total Current Liabilities had a median value of $44.7 million in 2023 and averaged $52.6 million.
  • As far as peak fluctuations go, Autolus Therapeutics' Total Current Liabilities dropped by 5.75% in 2022, and later spiked by 66.61% in 2025.
  • Quarterly analysis of 5 years shows Autolus Therapeutics' Total Current Liabilities stood at $28.6 million in 2021, then skyrocketed by 62.40% to $46.4 million in 2022, then declined by 3.51% to $44.7 million in 2023, then soared by 35.78% to $60.7 million in 2024, then surged by 58.31% to $83.1 million in 2025.
  • Its Total Current Liabilities stands at $83.1 million for Q3 2025, versus $68.2 million for Q2 2025 and $66.6 million for Q1 2025.